Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will present at multiple scientific conferences in May. Scheduled conference presentations include the following: TIDES 2014 – Providence, RI, May 12-15 May 12, 2014 – An oral presentation titled, “ Using Endosomal Escape Agents for siRNA Delivery in vivo,” will be presented at the workshop entitled “In vivo Delivery of Therapeutic Oligonucleotides: Challenges, Considerations and Solutions,” by David Lewis, Ph.D., Chief Scientific Officer May 14, 2014 – An oral presentation titled, “ Next Generation Dynamic Polyconjugates for siRNA Delivery in vivo,” will be presented by Aaron Almeida, Ph.D., Senior Scientist II 10th International Symposium on Polymer Therapeutics – Valencia, Spain, May 19-21 May 19, 2014 – An oral presentation titled, “ Polymer-Based Vehicles for siRNA Delivery in vivo,” will be presented by David Rozema, Ph.D., Vice President, Chemistry ASGCT 17 th Annual Meeting – Washington, DC, May 21-24 May 21, 2014 – An oral presentation titled, “ Development of an siRNA-Based Therapeutic for Chronic HBV Infection Using DPC Technology,” will be presented by David Lewis, Ph.D., Chief Scientific Officer About Arrowhead Research Corporation Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and partner-based programs in obesity and oncology. For more information please visit http://www.arrowheadresearch.com, or follow us on Twitter @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to email@example.com.